Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,164,158
-$1,078,000 QoQ
Shares Held
8,282
+2.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
3.38%
of 13F equity value
Holder Rank
#387
of 1,322 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ELLERSON GROUP INC /ADV holds $5,380,931 across 2 Biotechnology names. REGN ranks #1 (96.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
8,282 | $5,164,158 | |
| 2 | CGON |
CG Oncology, Inc.
|
3,051 | $216,773 |
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,164,158 | 8,282 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,242,158 | 8,079 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,201,975 | 8,035 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,555,511 | 8,102 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,851,275 | 5,431 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,163,900 | 8,142 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,929,323 | 6,920 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $7,212,557 | 6,861 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,344,597 | 6,988 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $6,806,729 | 7,072 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,231,467 | 7,095 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,838,901 | 7,095 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,194,325 | 7,229 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,800,168 | 7,059 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $5,095,883 | 7,063 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||